共查询到19条相似文献,搜索用时 62 毫秒
1.
2.
1口蹄疫概述口蹄疫是什么?它是由口蹄疫病毒引起的一种偶蹄动物病毒性传染病,临床上以口部和蹄部皮肤发生水疱和烂斑为主要特征。具有传染性强、发病率高、传播速度快等特点。虽然此病的病死率不高,但可引起动物生产力下降,因此,对养殖场的经济影响很大,OIE也将其列为A类传染病的首位。口蹄疫一般症状为:发热、厌食、水疱(口腔部、蹄部、乳房周围)、流涎、跛行。临床诊断中猪 相似文献
3.
4.
在口蹄疫病毒粒子的四种多肽中,仅一种(Vp1)具有免疫学活性。用两种方法确定了Vp1上的主要免疫原决定子。首先,检测用化学或蛋白水解酶裂解而来的片段的免疫原活性,根据核苷酸序列的一致性将这些片段末端氨基酸序列与完整的Vp1序列比较,从而来定位那些有效片段。其次,不同病毒血清型的Vp1在序列上的不同,其在抗原重要区段上承担作用也各不相同,依据二者相似程度,可以确定两者序列,141—160和200—213氨基酸序列有免疫学活性。141—160序列可以用固相法或当作融合蛋白的一部分来合成,能诱发高水平中和抗体产生和防止牛感染。 相似文献
5.
6.
为探讨三肽囊素(Bursin)模拟七肽的免疫活性及其与Brusin的相关性,本研究根据Bursin阳性噬菌体展示七肽库中筛选得到的氨基酸序列(MTTNLQQ)人工合成该七肽.以ELISA和竞争ELISA检验合成七肽与Bursin在体外的免疫学反应的相关性;比较不同剂量的合成七肽(设定Bursin作为对照)对鸡新城疫病毒(NDV)弱毒疫苗(La sota株)在鸡体诱导的特异性免疫应答的影响.结果显示合成七肽与抗Bursin单克隆抗体(2F9-4/HU2)能够特异性结合并且该结合作用可被Bursin阻断;动物试验的结果表明,低剂量(0.09 mg)的合成七肽对疫苗诱导的体液免疫应答的增强作用与Bursin相当,而且高剂量(0.3 mg)的合成七肽对细胞免疫应答具有一定的增强作用.因此,认为七肽序列MTTNLQQ具有与Bursin类似的免疫活性. 相似文献
8.
9.
10.
11.
《广东畜牧兽医科技》2012,37(4)
设3组猪群,首免和二免分别注射生理盐水1mL、猪口蹄疫0型合成肽疫苗1mL(说明书推荐免疫剂量)及猪口蹄疫0型合成肽疫苗3mL(说明书推荐免疫剂量3倍量),二免28天后检测猪群的13'蹄疫抗体,结果显示3组猪群的抗体合格率分别为33%、78%和100%,疫苗诱导的抗体水平达到农业部规定的动物强制免疫标准。 相似文献
12.
设3组猪群,首免和二免分别注射生理盐水1 mL、猪口蹄疫0型合成肽疫苗1 mL(说明书推荐免疫剂量)及猪口蹄疫0型合成肽疫苗3 mL(说明书推荐免疫剂量3倍量),二免28天后检测猪群的口蹄疫抗体,结果显示3组猪群的抗体合格率分别为33%、78%和100%,疫苗诱导的抗体水平达到农业部规定的动物强制免疫标准。 相似文献
13.
活菌载体疫苗的研究概述 总被引:3,自引:0,他引:3
活菌载体疫苗是指将病原菌特异性抗原基因片段插入已知细菌中,以提呈表达所编码的抗原。因其具有安全性好、生产费用低、易于构建多价疫苗、能激起持久的系统和黏膜免疫反应且兼具免疫佐剂作用等优势,已成为疫苗领域的研究热点。目前,对活菌载体的研究主要集中在沙门氏菌、牛分枝杆菌-卡介苗(BCG)、志贺菌、单核细胞增多性李斯特杆菌等,本文主要对这类载体及疫苗研究做一概述。 相似文献
14.
本试验利用生物软件对H5亚型禽流感病毒A/CK/GD/178/04的血凝素进行抗原特性分析,结合关于禽流感病毒血凝素抗原位点的文献报道,选定97~212位氨基酸和369~529位氨基酸两个区域作为多肽表位候选区域.利用本实验室自主研发的原核表达载体pBT载体,串联表达HA的两个区域,经SDS-PAGE和Western Blotting分析,证明重组产物得到表达,Ni2+柱纯化重组蛋白后,对2周龄SPF鸡进行免疫,经HI试验检测该重组蛋白可以刺激机体产生HI抗体.本研究为H5亚型AIV多肽疫苗的进一步研制奠定了基础. 相似文献
15.
Objective To investigate the effects of two doses (200 and 400 mg) of a water-soluble gonadotrophin-releasing hormone vaccine on the ovarian activity of 2-year-old fillies.
Design A controlled vaccination dose rate experiment.
Animals Six 2-year-old Australian Stock Horse fillies were randomly allocated to three treatment groups: unvaccinated controls, those receiving 200 mg of the vaccine and those receiving 400 mg of the vaccine.
Results Ovarian activity of the treated fillies was suppressed at the peak of the breeding season while that of the untreated controls continued normally. The control fillies displayed oestrous activity and behaviour. Suppression of ovarian activity occurred for 25 and 30 weeks in the 200 and 400 mg groups, respectively. These differences were not significant. Ovarian activity ceased 2 to 3 weeks after primary vaccination. Antibody titres were low (330) until after the booster immunisation when they rapidly peaked at 22,000 and 28,000 in the 200 mg and 400 mg groups, respectively. Plasma progesterone concentrations of the treated fillies remained below 3.18 nmol/L while GnRH was suppressed. The vaccine had no significant effect on plasma androstenedione concentrations. Recovery from the effect of the vaccine was associated with development of ovarian follicles, normal oestrous behaviour and ovulation. Three of the four treated fillies and one of the controls conceived during the next breeding season and foaled normally. All the treated fillies conceived and produced normal foals in the following two breeding seasons.
Conclusion Both dose rates suppressed ovarian function and prevented oestrous behaviour. These effects were reversible and the subsequent fertility of the vaccinated fillies was normal. 相似文献
Design A controlled vaccination dose rate experiment.
Animals Six 2-year-old Australian Stock Horse fillies were randomly allocated to three treatment groups: unvaccinated controls, those receiving 200 mg of the vaccine and those receiving 400 mg of the vaccine.
Results Ovarian activity of the treated fillies was suppressed at the peak of the breeding season while that of the untreated controls continued normally. The control fillies displayed oestrous activity and behaviour. Suppression of ovarian activity occurred for 25 and 30 weeks in the 200 and 400 mg groups, respectively. These differences were not significant. Ovarian activity ceased 2 to 3 weeks after primary vaccination. Antibody titres were low (330) until after the booster immunisation when they rapidly peaked at 22,000 and 28,000 in the 200 mg and 400 mg groups, respectively. Plasma progesterone concentrations of the treated fillies remained below 3.18 nmol/L while GnRH was suppressed. The vaccine had no significant effect on plasma androstenedione concentrations. Recovery from the effect of the vaccine was associated with development of ovarian follicles, normal oestrous behaviour and ovulation. Three of the four treated fillies and one of the controls conceived during the next breeding season and foaled normally. All the treated fillies conceived and produced normal foals in the following two breeding seasons.
Conclusion Both dose rates suppressed ovarian function and prevented oestrous behaviour. These effects were reversible and the subsequent fertility of the vaccinated fillies was normal. 相似文献
16.
Yamane T Takemura N Inoue H Soeta S Oishi M Amasaki H 《The Journal of veterinary medical science / the Japanese Society of Veterinary Science》2011,73(3):375-378
We examined the immunohistochemical distributions of natriuretic peptide receptor (NPR)-A, -B and -C that bind with natriuretic peptide hormones A, B and C in four healthy crossbreed young canine and feline cardiac tissues using specific antibodies against human antigens. Cross-immunoreactivities between antigens and antibodies were confirmed using western blot analysis. NPR-A and -C were expressed more strongly in dogs than cats. In both species, these expressions were stronger in the atria than the ventricles, with stronger expression in the left ventricles than the right. NPR-B was largely very weekly or undetected. In canine and feline cardiac tissues, the expressional distribution of NPR-A, -B, and -C closely matched with that of atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide as the ligands for corresponding receptors. 相似文献
17.
《中国兽医杂志》2015,(8)
为了建立一种以合成肽为抗原的猪繁殖与呼吸障碍综合征病毒抗体ELISA检测试剂盒,通过多肽序列的筛选、合成及反应原性的鉴定后,将多肽与非蛋白结构多聚体载体进行偶联,利用偶联后的多肽作为抗原,通过方阵滴定确定偶联多肽、血清、HRP的最佳工作浓度以及阴阳性临界值,再以特异性试验、敏感度测定和临床猪血清样本的免疫效果评估等方法进行确证。结果表明,偶联多肽具有良好的反应原性,其最佳包被浓度为0.5μg/m L,血清最佳稀释度为1∶40,HRP最佳稀释度为1∶4 000。本试验建立的猪繁殖与呼吸障碍综合征病毒抗体检测试剂盒可以用于临床猪血清抗体的检测,且该方法特异性好、敏感度高、操作方便省时。 相似文献
18.
给猪口服和肌肉注射以乳酸杆菌为载体的口蹄疫病毒VP1基因DNA疫苗(L.acido SFMD-1),以正向间接血凝试验(IHA)和MTT方法分别检测了免疫后FMDV VP1抗体的动态变化和特异性T细胞增殖反应情况,并与商用FMD油佐剂疫苗、裸质粒FMDV VP1基因DNA疫苗诱导的特异性免疫抗体水平进行了比较。结果显示,口服组猪在免疫后第21d抗体效价达到了1:2^7.7,而肌肉注射组猪为1:2^3.3。加强免疫后2周,口服免疫组抗体水平下降到1:2^5.3,到第3周快速上升到1:2^8;与此相对应,肌肉途径免疫组猪抗体效价缓慢地从1:2^5.3上升到1:2^6.7。口服途径和肌肉注射途径的刺激指数(SI)分别为1.93和2.00,2种免疫途径都可以诱导特异性T细胞增殖反应。证实,该疫苗能够在猪体诱发VP1特异性T细胞和B细胞反应,以乳酸杆菌为载体是DNA免疫和预防猪口蹄疫的一种极有前景的方法。 相似文献
19.
Sales-Junior PA Guzman F Vargas MI Sossai S Patarroyo V AM González CZ Patarroyo JH 《Veterinary immunology and immunopathology》2005,107(3-4):281-290
The synthetic anti-Boophilus microplus vaccine SBm7462 derived from the tick intestinal protein, Bm86, induced a protective immune response when emulsified in saponin and used in cattle. Using a mice model, and with the objective of improving the vaccine by continual peptide release, it was encapsulated in PLGA 50:50 microspheres and inoculated in BALB/c mice to assess the immunological response by detection of anti-peptide IgGs. Comparative studies were made with the peptide emulsified in saponin and with another synthetic vaccine, and the microsphere/peptide was characterized for efficiency of encapsulation, in vitro release profile, morphology, size, peptide integrity after encapsulation and stability in different pHs. The findings showed that saponin enhances a better immune response from SBm7462 and that the PLGA 50:50 microspheres are suitable for use with this peptide. 相似文献